Common Contracts
3 similar Settlement and License Agreement contracts by Endo Health Solutions Inc.
EX-10.1 2 d359761dex101.htm SETTLEMENT AND LICENSE AGREEMENT Execution Version SETTLEMENT AND LICENSE AGREEMENTSettlement and License Agreement • May 5th, 2020 • Delaware
This Settlement and License Agreement (this “Agreement”) is entered into by and between Endo Pharmaceuticals Inc. (“Endo”), Teikoku Pharma USA, Inc. (“TPU”), Teikoku Seiyaku Co., Ltd. (“Teikoku Seiyaku,” and together with TPU, “Teikoku”, and collectively with Endo, “Endo/Teikoku”), on the one hand, and Watson Laboratories, Inc. (“Watson”), on the other hand. Endo, TPU, Teikoku Seiyaku and Watson are individually referred to herein by name or the term “Party” and are referred to collectively herein as the “Parties.” This Agreement is entered into on and is effective as of May 28, 2012 (the “Effective Date”).
SETTLEMENT AND LICENSE AGREEMENTSettlement and License Agreement • April 23rd, 2016 • Delaware
This Settlement and License Agreement (this “Agreement”) is entered into by and between Endo Pharmaceuticals Inc. (“Endo”), Teikoku Pharma USA, Inc. (“TPU”), Teikoku Seiyaku Co., Ltd. (“Teikoku Seiyaku,” and together with TPU, “Teikoku”, and collectively with Endo, “Endo/Teikoku”), on the one hand, and Watson Laboratories, Inc. (“Watson”), on the other hand. Endo, TPU, Teikoku Seiyaku and Watson are individually referred to herein by name or the term “Party” and are referred to collectively herein as the “Parties.” This Agreement is entered into on and is effective as of May 28, 2012 (the “Effective Date”).
SETTLEMENT AND LICENSE AGREEMENTSettlement and License Agreement • May 29th, 2012 • Endo Health Solutions Inc. • Pharmaceutical preparations • Delaware
This Settlement and License Agreement (this “Agreement”) is entered into by and between Endo Pharmaceuticals Inc. (“Endo”), Teikoku Pharma USA, Inc. (“TPU”), Teikoku Seiyaku Co., Ltd. (“Teikoku Seiyaku,” and together with TPU, “Teikoku”, and collectively with Endo, “Endo/Teikoku”), on the one hand, and Watson Laboratories, Inc. (“Watson”), on the other hand. Endo, TPU, Teikoku Seiyaku and Watson are individually referred to herein by name or the term “Party” and are referred to collectively herein as the “Parties.” This Agreement is entered into on and is effective as of May 28, 2012 (the “Effective Date”).
